Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Buy
19,598
+6,004
+44% +$418K 0.04% 318
2025
Q4
$902K Buy
+13,594
New +$879K 0.03% 347
2023
Q3
Sell
-1,907
Closed -$245K 654
2023
Q2
$245K Sell
1,907
-77
-4% -$9.31K 0.01% 546
2023
Q1
$231K Buy
1,984
+60
+3% +$6.72K 0.01% 482
2022
Q4
$218K Buy
+1,924
New +$211K 0.01% 485
2022
Q3
Sell
-2,988
Closed -$223K 503
2022
Q2
$223K Sell
2,988
-848
-22% -$77.4K 0.02% 488
2022
Q1
$491K Sell
3,836
-660
-15% -$72.2K 0.03% 352
2021
Q4
$604K Sell
4,496
-240
-5% -$34.5K 0.04% 333
2021
Q3
$648K Buy
4,736
+24
+0.5% +$3.03K 0.04% 304
2021
Q2
$503K Buy
4,712
+220
+5% +$21.1K 0.03% 341
2021
Q1
$404K Hold
4,492
0.03% 368
2020
Q4
$415K Buy
4,492
+888
+25% +$79.3K 0.03% 348
2020
Q3
$372K Buy
3,604
+764
+27% +$79.8K 0.03% 333
2020
Q2
$288K Sell
2,840
-268
-9% -$24K 0.03% 368
2020
Q1
$209K Sell
3,108
-596
-16% -$37.1K 0.02% 388
2019
Q4
$202K Buy
+3,704
New +$176K 0.02% 454

Other funds holding DXCM

Argent Trust Co's DXCM Position: Q1 2026 in Review

Argent Trust Co increased its DexCom (DXCM) stake by 44% in Q1 2026, buying an estimated $418K and bringing the position to 19,598 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #318.

Argent Trust Co first reported a position in DXCM in Q4 2019 and has held it in 16 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Argent Trust Co held 19,598 shares of DexCom worth $1.23M as of Q1 2026.
  • Argent Trust Co bought 6,004 DexCom shares in Q1 2026, an estimated $418K.
  • DexCom made up 0.04% of Argent Trust Co's portfolio in Q1 2026, its #318 holding.
  • Argent Trust Co first reported a position in DexCom in Q4 2019 and has held it in 16 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.